Turnover
≈ €110,000 estimated
The micro format states no turnover.
Dr. Jill Devriese
Lifetime
3 annual accounts with figures on one time axispeak €52,552 (2024)
€35,456▼ 32.5%
peak €40,710 (2024)
€27,693▼ 32.0%
peak €70,403 (2025)
€70,403▲ 64.8%
€13,581▼ 33.3%
Board1 name since 2023
1 director
Documentsfilings and deeds
20-01-202611 days before the deadline
2025micro format
Gross margin from €52,552 to €35,456Result from €40,710 to €27,693Equity from €42,710 to €70,403Debts from €20,373 to €13,581Cash from €54,276 to €30,536
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as Dr. Jill Devriese has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for Dr. Jill Devriese. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0802948677
Registered office moved within Brasschaat
New registered office: Bloemaard 2, 2930 Brasschaat · Previous registered office: Bredestraat 61, 2930 Brasschaat · General meeting of 28-08-2023 · Gazette deed
Incorporation
Founder: · 100 shares · Appointment: (director) · published on 22-06-2023 · Gazette deed
First establishment
Bloemaard 2, Brasschaat
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Jill Devriese Brasschaat | €83,984 | €35,456 | 83.8% | - |
| Dr. Dieter Thijs Neurochirurgie Antwerp | €76,463 | €34,407 | 66.4% | - |
| Dr. Thomas De Ridder Herentals | €89,601 | €39,392 | 67.1% | - |
| Docteur Cécile Debabèche Liège | €94,616 | €36,611 | 80.3% | - |
| EVANES Woluwe-Saint-Pierre | €81,829 | €37,745 | 84.7% | - |
| Regal Clinics Kalmthout | €98,347 | €31,026 | 36.8% | - |
| Medi-Mind Dessel | €73,530 | €42,386 | 65.9% | - |
These companies have the same main activity as Dr. : specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €73,500 and €98,300, founded between 2022 and 2024.
Official details
Source: KBO- Status
- Active since 20-06-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.346.382.5872930 Brasschaat, since 20-06-2023
- Financial year end
- 30 June
- Peppol
- Reachable since 11-02-2025
Annual accounts to 30-06-2025
- €83,984▲ 33.1%
- Filing
- Filed on 20-01-2026, 11 days before the end of the filing period
Insights on Dr. Jill Devriese
Dr. has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €70,403 and a net result of €27,693.
Equity has been growing by about 493% per year since 2023. Its solvency ranks better than 75% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. Jill Devriese
- What is the company number of Dr. Jill Devriese?
- The company number of Dr. is 0802.948.677. The VAT number is the same number with BE in front: BE 0802.948.677.
- Where is Dr. Jill Devriese based?
- The registered office is at Bloemaard 2, 2930 Brasschaat.Company details
- What does Dr. Jill Devriese do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. Jill Devriese?
- Dr. is a private limited company (BV).
- When was Dr. Jill Devriese founded?
- Dr. was founded on 20-06-2023.
- Is Dr. Jill Devriese still active?
- Yes, Dr. is an active enterprise in the KBO register.
- What is the turnover of Dr. Jill Devriese?
- The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €35,456 and 47 comparable companies (NACE 86). It probably lies between €79,000 and €150,000.Financials
- Is Dr. Jill Devriese profitable?
- In financial year 2025, Dr. made a profit of €27,693.
- Where can I find the annual accounts of Dr. Jill Devriese?
- Dr. filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. Jill Devriese due?
- Dr. must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.